Literature DB >> 29314455

Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative.

João Pedro Ferreira1,2, Kevin Duarte3,4,5, Marc A Pfeffer6, John J V McMurray7, Bertram Pitt8, Kenneth Dickstein9, Faiez Zannad1, Patrick Rossignol1.   

Abstract

BACKGROUND: Observational data have described the association of blood pressure (BP) with mortality as 'J-shaped', meaning that mortality rates increase below a certain BP threshold. We aimed to analyse the associations between BP and prognosis in a population of acute myocardial infarction (MI) patients with heart failure (HF) and/or systolic dysfunction. METHODS AND
RESULTS: The datasets included in this pooling initiative are derived from four trials: CAPRICORN, EPHESUS, OPTIMAAL, and VALIANT. A total of 28 771 patients were included in this analysis. Arithmetic means of all office BP values measured throughout follow-up were used. The primary outcome was cardiovascular death. The mean age was 65 ± 11.5 years and 30% were female. Patients in the lower systolic BP (SBP) quintiles had higher rates of cardiovascular death (reference: SBP 121-128 mmHg) [adjusted hazard ratio (HR) 2.49, 95% confidence interval (CI) 2.26-2.74 for SBP ≤112 mmHg, and HR 1.29, 95% CI 1.16-1.43 for SBP 113-120 mmHg]. The findings for HF hospitalization and MI were similar. However, stroke rates were higher in patients within the highest SBP quintile (reference: SBP 121-128 mmHg) (HR 1.38, 95% CI 1.11-1.72). Patients who died had a much shorter follow-up (0.7 vs. 2.1 years), less BP measurements (4.6 vs. 9.8) and lower mean BP (-8 mmHg in the last SBP measurement compared with patients who remained alive during the follow-up), suggesting that the associations of low BP and increased cardiovascular death represent a reverse causality phenomenon.
CONCLUSION: Systolic BP values <125 mmHg were associated with increased cardiovascular death, but these findings likely represent a reverse causality phenomenon.
© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.

Entities:  

Keywords:  Blood pressure; Cardiovascular outcomes; Heart failure; Myocardial infarction

Mesh:

Year:  2018        PMID: 29314455     DOI: 10.1002/ejhf.1131

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  6 in total

1.  Gender Differences in Prognostic Markers of All-Cause Death in Patients with Acute Heart Failure: a Prospective 18-Month Follow-Up Study.

Authors:  Xiaoting Wu; Mengli Chen; Kai Wang; Rongrong Gao; Xinli Li
Journal:  J Cardiovasc Transl Res       Date:  2019-05-22       Impact factor: 4.132

2.  Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trial.

Authors:  João Pedro Ferreira; John Gregson; Michael Böhm; Patrick Rossignol; Faiez Zannad; Stuart J Pocock
Journal:  Clin Cardiol       Date:  2021-04-06       Impact factor: 2.882

3.  Different prognostic association of systolic blood pressure at different time points with postdischarge events in patients hospitalized for decompensated heart failure.

Authors:  You-Nan Yao; Rong-Cheng Zhang; Tao An; Qi Zhang; Xin-Ke Zhao; Jian Zhang
Journal:  J Geriatr Cardiol       Date:  2019-09       Impact factor: 3.327

Review 4.  Highlights in heart failure.

Authors:  Daniela Tomasoni; Marianna Adamo; Carlo Mario Lombardi; Marco Metra
Journal:  ESC Heart Fail       Date:  2019-12

5.  Tight versus standard blood pressure control on the incidence of myocardial infarction and stroke: an observational retrospective cohort study in the general ambulatory setting.

Authors:  Bumsoo Park; Katarzyna Budzynska; Nada Almasri; Sumaiya Islam; Fanar Alyas; Rachel L Carolan; Benjamin E Abraham; Pamela A Castro-Camero; Maria E Shreve; Della A Rees; Lois Lamerato
Journal:  BMC Fam Pract       Date:  2020-05-16       Impact factor: 2.497

6.  Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial.

Authors:  Magnus O Wijkman; Brian Claggett; Rafael Diaz; Hertzel C Gerstein; Lars Køber; Eldrin Lewis; Aldo P Maggioni; Emil Wolsk; David Aguilar; Rhonda Bentley-Lewis; John J McMurray; Jeffrey Probstfield; Matthew Riddle; Jean-Claude Tardif; Scott D Solomon; Marc A Pfeffer
Journal:  Cardiovasc Diabetol       Date:  2020-10-12       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.